Ardheshir Khadang

A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa.

A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa.

A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa.

A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa.

A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa.

A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa.

A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa.

A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa.

A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa.

A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa.

A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa.